✦ LIBER ✦

P1-338 Factors predicting the treatment response to cholinesterase inhibitors in Alzheimer's dementia

✍ Scribed by Elena Lucchi; Nadia Minicuci; Francesca Magnifico; Attilio Calza; Stefano Avanzi; Daniele Villani; Giuseppe Bellelli; Marco Trabucchi

Book ID: 117413213
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 161 KB
Volume: 25
Category: Article
ISSN: 0197-4580
DOI: 10.1016/s0197-4580(04)80651-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Can CSF biomarkers or pre-treatment prog

Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease?

✍ Å. K. Wallin; O. Hansson; K. Blennow; E. Londos; L. Minthon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 1 views

## Abstract ## Objective The main objective of this study was to investigate possible predictors of response to cholinesterase inhibitor (ChEI) treatment, including pre‐treatment progression rates and levels of the cerebrospinal fluid (CSF) biomarkers. A secondary objective was to evaluate whether

Responsiveness to cholinesterase inhibit

Responsiveness to cholinesterase inhibitors in Alzheimer's disease: A possible role for the 192 Q/R polymorphism of the PON-1 gene

✍ Roberto Pola; Andrea Flex; Michele Ciaburri; Emilio Rovella; Angela Valiani; Gia 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 62 KB

P3-002 Plasma levels of Abeta1–40 and Ab

P3-002 Plasma levels of Abeta1–40 and Abeta1–42 in Alzheimer's disease during treatment with the dual cholinesterase inhibitor rivastigmine

✍ Sobow, Tomasz; Kloszewska, Iwona 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Effect of initial response to treatment

Effect of initial response to treatment with a cholinesterase inhibitor on the course of cognition in patients with Alzheimer's disease: Results from the Frisian Alzheimer's disease cohort study

✍ Droogsma, E.; Diekhuis, M.; Veeger, N.; Blaauw, M.; Schuur, T.; van Steijn, J.; 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 68 KB

CE3 COST-UTILITY ANALYSIS OF CHOLINESTER

CE3 COST-UTILITY ANALYSIS OF CHOLINESTERASE INHIBITORS IN THE TREATMENT OF MILD TO MODERATE ALZHEIMER'S DISEASE

✍ Turongkaravee, S 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

How useful are cholinesterase inhibitors

How useful are cholinesterase inhibitors in the treatment of Alzheimer's disease? A number needed to treat analysis

✍ Gill Livingston; Cornelius Katona 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 2 views

Objectives. To report on a Numbers Needed to Treat (NNT) analysis of the literature identi®ed through a systematic review of trials of cholinesterase inhibitors in Alzheimer's Disease. Design. Search of Medline (1966±1998), EMBASE (1994±1999) and Psychlit (1974±1998) using the keywords cholinestera